P.L. 109-462, The Dietary Supplement and Nonprescription Drug and Consumer Protection Act (12 comments ↓)
- This item is from the 109th Congress (2005-2006) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
The Dietary Supplement and Nonprescription Drug Consumer Protection Act requires the Food and Drug Administration (FDA) to establish systems for collecting data about serious adverse reactions that people experience while using certain nonprescription drugs and dietary supplements. Manufacturers, packers, or distributors of such products will have to submit reports to FDA about serious adverse events based on specific information that they receive from the public.